Coffee with Coker
Download on the App Store

Coffee with Coker episodes

  • Episode 88: What is a Gainsharing Arrangement and How Do You Use Them Strategically?

    Max Reiboldt and Tom Anthony (Frost Brown Todd LLC) join Mark to discuss gainsharing as an affiliation strategy. Max and Tom define gainsharing with a high-level legal overview, talk about a scenario where gainsharing works, and share their observations from Advisory Opinion 17-09.

    Podcast Information

    Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review!

    We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.

    -- Please email us: [email protected]

    -- Connect with us on LinkedIn: Coker Group Company Page

    -- Follow us on Twitter: @cokergroup

    -- Follow us on Instagram: @cokergroup

    -- Follow us on Facebook: @cokerconsulting

    Episode Synopsis

    Max and Tom review the positive outcome of Advisory Opinion 17-09 and how to use gainsharing as a physician-hospital affiliation strategy. They define gainsharing and its objectives, discuss how a gainsharing arrangement is applicable for a joint replacement, and offer their insight on using gainsharing arrangements as an affiliation strategy.

    Click the play button to listen to the episode.

    Extras

    OIG Advisory Opinion No. 17-09

    Why is a Fair Market Value/Commercial Reasonableness Opinion Important for Value-Based Enterprises?

    Learn more about Fair Market Value and Commercial Reasonableness

    37 min
  • Episode 87: Pandemics, Policy Changes, and Value-Based Care, Oh My

    Justin Chamblee and Alex Kirkland join Mark to review the status of value-based models, evaluate the potential impacts of recent events on value-based models, and reflect on real-world implementation challenges and practical strategies.

    Podcast Information

    Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review!

    We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.

    • Please email us: [email protected]
    • Connect with us on LinkedIn: Coker Group Company Page
    • Follow us on Twitter: @cokergroup
    • Follow us on Instagram: @cokergroup
    • Follow us on Facebook: @cokerconsulting

    Episode Synopsis

    Justin and Alex discuss new developments in value-based reimbursement and how the different administrations have viewed the shift to value-based reimbursement. Much change has occurred in the healthcare industry with the pandemic and healthcare regulation changes. Justin and Alex discuss how these changes will affect value-based compensation.

    Click the play button to listen to the episode.

    Extras

    Request a call with Justin or Alex to discuss your value-based compensation approach

    Will Innovation Capture Value-Based Market Share?

    Incorporating Value-Based Metrics into a Physician Compensation Plan

    38 min
  • Episode 86: How to Use an MSO as a Strategy to Grow

    Max Reiboldt and Andy Sobczyk join Mark to discuss the next generation of management service organizations (MSOs) and business service organizations (BSOs). The presence of MSOs, entities that provide an array of administrative support services to physician practices, has grown significantly in recent years. This trend is linked to private equity (PE) entry in the physician practice space because many PE transactions include an MSO.

    Podcast Information

    Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review!

    We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.

    • Please email us: [email protected]
    • Connect with us on LinkedIn: Coker Group Company Page
    • Follow us on Twitter: @cokergroup
    • Follow us on Instagram: @cokergroup
    • Follow us on Facebook: @cokerconsulting

    Episode Synopsis

    Max and Andy discuss the differences between MSOs and BSOs, and their goals and services. MSOs are not unique to private equity deals, and they are growing in popularity. Max and Andy discuss how to use an MSO or BSO as a growth strategy for your healthcare organization.

    Click the play button to listen to the episode.

    Extras

    Request a copy of the detailed presentation with organizational structure examples!

    Next Generation MSOs: Strategies to Grow beyond Traditional Practice Management Services

    Affiliation Options for Physicians: Current and Future Strategies

    32 min
  • Episode 85: Non-Economic Considerations for Private Equity Transactions

    Max Reiboldt joins Mark to discuss the non-economic terms to consider when pursuing a private equity deal. The non-economic components are often more important than the economic terms because they dictate the day-to-day after closing the deal.

    Podcast Information

    Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review!

    We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.

    • Please email us: [email protected]
    • Connect with us on LinkedIn: Coker Group Company Page
    • Follow us on Twitter: @cokergroup
    • Follow us on Instagram: @cokergroup
    • Follow us on Facebook: @cokerconsulting

    Episode Synopsis

    Max and Mark discuss their experience with private equity transactions and which non-economic terms to consider when pursuing a private equity deal. One of the lessons we impart to medical practice and hospital clients contemplating a private equity (PE) transaction is that both the economic and non-economic terms carry weight. They should receive equal consideration before signing on the dotted line.

    Click the play button to listen to the episode.

    Extras

    Episode 56: Private Equity Deals: Operational Components of the Transaction

    The Role of Management Services in Private Equity Transactions

    Episode 55: Private Equity Deals: Approaching a Deal Strategically

    Defining Private Equity Transactions in Healthcare and Understanding Deal Options for Medical Groups

    38 min
  • Episode 84: Recovering from the Pandemic: Hospital Pain Points and Challenges

    Michele Madison, a partner in the healthcare practice at Morris, Manning & Martin, LLP, joins Mark to discuss hospital pain points and challenges in the wake of 2020. They touch on compliance, transactions, E/M coding changes, financial challenges, telehealth, and handling the various hardships that have grown over the last year of COVID.

    Podcast Information

    Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review!

    We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.

    • Please email us: [email protected]
    • Connect with us on LinkedIn: Coker Group Company Page
    • Follow us on Twitter: @cokergroup
    • Follow us on Instagram: @cokergroup
    • Follow us on Facebook: @cokerconsulting

    Episode Synopsis

    Michele and Mark discuss maintaining physician relationships and focusing on value-based care and cost-reducing strategies. Hospitals are also exploring how to develop and expand outpatient healthcare delivery to patients.

    They also discuss the implications of the weighting changes to the work RVU values and how these changes affect commercial reasonableness and fair market value. How will these changes affect the upcoming survey data that many physician enterprises rely on?

    Click the play button to listen to the episode.

    Extras

    Learn more about Michele

    2021 Offers New Opportunities Amid Healthcare Regulation Changes

    Episode 82: How the MPFS Final Rule Impacts Medical Practices (and What to Do about It)

    Webinar Replay: 2021 E/M Coding Changes: What Healthcare Professionals Need to Know

    32 min
  • Episode 83: Updates to the Final Medicare Physician Fee Schedule Rule

    Alex Kirkland joins Mark to discuss changes to the Medicare Physician Fee Schedule (MPFS) final rule. On December 27, 2020, Congress passed and the President signed into law the Consolidated Appropriations Act. The stimulus bill provided temporary relief by partially mitigating cuts to the conversion factor in 2021.

    Podcast Information

    Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review!

    We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.

    • Please email us: [email protected]
    • Connect with us on LinkedIn: Coker Group Company Page
    • Follow us on Twitter: @cokergroup
    • Follow us on Instagram: @cokergroup
    • Follow us on Facebook: @cokerconsulting

    Episode Synopsis

    Many payers use the Physician Fee Schedule (PFS) as the foundation for their rates and how they set their conversion factor. Although the stimulus bill only affects Medicare reimbursement for physician professional services, the impact will extend beyond Medicare. The stimulus package provides support only during 2021, so the full 10% cut to the conversion factor is still expected in 2022.

    Medical groups need to analyze their financial impact through a CPT level revenue and wRVU compensation analysis. The important concept is compensation increases should not outpace reimbursement, meaning you can't afford to pay more than your revenue allows.

    There are also fair market value (FMV) and commercially reasonable (CR) implications and issues to consider. The new regulations state that a hospital may not value a physician's services at a higher rate than a private equity investor or another physician practice.

    Click the play button to listen to the episode.

    Extras

    Estimate the Financial Impact of 2021 E/M Coding Changes

    Episode 82: How the MPFS Final Rule Impacts Medical Practices (and What to Do about It)

    Webinar Replay: 2021 E/M Coding Changes: What Healthcare Professionals Need to Know

    23 min
  • Episode 82: How the MPFS Final Rule Impacts Medical Practices (and What to Do about It)

    Aimee Greeter and Taylor Cowart join Mark to unpack how the Medicare Physician Fee Schedule (MPFS) final rule impacts medical practices (both employed and private), and offer suggestions to handle the 2021 changes to wRVUs and Medicare reimbursement for professional services.

    Podcast Information

    Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review! Not there? Let us know!

    We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.

    • Please email us: [email protected]
    • Connect with us on LinkedIn: Coker Group Company Page
    • Follow us on Twitter: @cokergroup
    • Follow us on Instagram: @cokergroup
    • Like us on Facebook: @cokerconsulting

    Episode Synopsis

    COVID-19 drew everyone's focus in 2020, and the surges around the holidays have moved the battlefront and center. In the fray, the Centers for Medicare and Medicaid Services announced big changes to evaluation and management codes that few are prepared for. Budget neutrality dictates there will be "winners" and "losers" throughout 2021.

    Aimee and Taylor provide an overview of how the final rule will affect certain specialties, and what hospitals and private medical practices need to do.

    Click the play button to listen to the episode.

    Extras

    E/M and ME: How Will the 2021 E/M Coding Changes Impact Medical Practices?

    Estimate the Financial Impact of 2021 E/M Coding Changes

    PSA Progression: What's Next in the Evolution of Professional Services Agreements?

    30 min
  • Episode 81: How to Quantify Risk with the Distress Index

    Richard Romero and Jeremy Johnson join Mark to discuss the Polsinelli|TrBK Distress Indices, which track bankruptcy statistics. The Distress Index is designed to capture distress in the market place and quantitatively present market place stress for healthcare valuators.

    Podcast Information

    Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review! Not there? Let us know!

    We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.

    • Please email us: [email protected]
    • Connect with us on LinkedIn: Coker Group Company Page
    • Follow us on Twitter: @cokergroup
    • Follow us on Instagram: @cokergroup
    • Like us on Facebook: @cokerconsulting

    Episode Synopsis

    Jeremy provides an overview of the Distress Index and how one could use the index to understand distress in the healthcare market. The Distress Index tracks all Chapter 11 bankruptcies, and there are two sub-indices for real estate and healthcare.

    Throughout this episode, Mark, Richard, and Jeremy explain how consultants and valuators use this data to understand the healthcare market and apply it to healthcare valuation. Risk is a significant factor in healthcare valuation and transaction advisory services. The Distress Index helps quantify the level of industry risk.

    Click the play button to listen to Richard and Jeremy discuss the Distress Index.

    Extras

    The Distress Index

    Blog: Recognizing and Mitigating Key Areas of Risk

    Blog: The Impact of COVID-19 on Business Valuation

    53 min
  • Episode 80: Top Five Healthcare Trends in 2021

    Taylor Cowart and Max Reiboldt join Mark to discuss the top five trends they expect to see during 2021. COVID-19 changed the entire world in just a matter of weeks, completely upending the status quo. Max and Taylor discuss how these changes will affect the healthcare industry in 2021 and beyond.

    Podcast Information

    Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review! Not there? Let us know!

    We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.

    • Please email us: [email protected]
    • Connect with us on LinkedIn: Coker Group Company Page
    • Follow us on Twitter: @cokergroup
    • Follow us on Instagram: @cokergroup
    • Like us on Facebook: @cokerconsulting

    Episode Synopsis

    Top Five Healthcare Trends for 2021

    1. Post-COVID Transactions
    2. Political Transition
    3. Value-Based Arrangements
    4. Operations and Efficiencies
    5. Telehealth

    Click the play button to listen to Max and Taylor discuss these five trends.

    Extras

    Blog Post: Top Five Healthcare Trends for 2021

    2020 Telehealth Survey – Summary of Results

    2020 Telehealth Survey – Summary of Results, Part 2

    45 min
  • Episode 79: Pandemic Exposes Vulnerabilities in Healthcare Organizations

    Coffee with Coker host, Mark Reiboldt, reviews the lessons we learned from the pandemic in 2020 and considers how to apply these lessons to a crisis moving forward.

    Contact Information

    Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, Audible, or your preferred podcast provider. Like what you hear? Leave a review! Not there? Let us know!

    We welcome all feedback from our listeners. Email us questions on any of the topics we discuss or questions about issues that interest you. You can also provide recommendations on matters for future episodes.

    • Please email us: [email protected]
    • Connect with us on LinkedIn: Coker Group Company Page
    • Follow us on Twitter: @cokergroup
    • Follow us on Instagram: @cokergroup
    • Like us on Facebook: @cokerconsulting

    Episode Synopsis

    Mark discusses the weaknesses and vulnerabilities the pandemic exposed in healthcare organizations. Ideally, if we can identify and address these vulnerable areas pre-crisis, we can mitigate the severity once a crisis arises.

    Mark reviews three categories: financial planning and performance, technology and compliance, and operations.

    Extras

    COVID-19 Pandemic Exposes Vulnerabilities in Healthcare Organizations (Part 1)

    COVID-19 Pandemic Exposes Vulnerabilities in Healthcare Organizations (Part 2)

    COVID-19 Pandemic Exposes Vulnerabilities in Healthcare Organizations (Part 3)

    24 min

About Coffee with Coker

From the publisher's feed

As healthcare business consultants, we are committed to helping healthcare organizations and professionals navigate the healthcare industry. Our discussion will focus on current events in the…